L'Amar Healthcarre Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-12-2024
- Paid Up Capital ₹ 0.10 M
as on 26-12-2024
- Company Age 14 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -73.91%
(FY 2022)
- Profit 6.51%
(FY 2022)
- Ebitda -15.07%
(FY 2022)
- Net Worth -9.27%
(FY 2022)
- Total Assets -48.18%
(FY 2022)
About L'Amar Healthcarre
The Corporate was formerly known as Lamar Healthcare Private Limited. The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Geeta Lulla, Shonaal Lulla, and Shailesh Patel serve as directors at the Company.
- CIN/LLPIN
U74900MH2010PTC202951
- Company No.
202951
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 May 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at L'Amar Healthcarre?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Lulla  | Director | 26-Jul-2010 | Current |
| Shonaal Lulla | Director | 26-Jul-2010 | Current |
| Shailesh Patel | Director | 29-Aug-2018 | Current |
Financial Performance of L'Amar Healthcarre.
L'Amar Healthcarre Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 73.91% decrease. The company also saw a slight improvement in profitability, with a 6.51% increase in profit. The company's net worth dipped by a decrease of 9.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of L'Amar Healthcarre?
Unlock access to L'Amar Healthcarre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
L'amar Natural Product Private LimitedActive 29 years 7 monthsGeeta Lulla, Shonaal Lulla and 1 more are mutual person
Amar-Deep Pharmas LlpActive 13 years 8 monthsGeeta Lulla, Shonaal Lulla and 1 more are mutual person
- Renaissance Lifesciences India LlpActive 13 years 5 months
Geeta Lulla, Shonaal Lulla and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at L'Amar Healthcarre?
L'Amar Healthcarre has a workforce of 20 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of L'Amar Healthcarre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped L'Amar Healthcarre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
